Insider · CIK 0001867310

Farid Adrienne

Reports to the SEC for 1 company · PHILADELPHIA, PA

sec.gov

Transactions

Companies

Filings

CIK

0001867310

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-06-09	IPSCCentury Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−552 sh	$0.62	−$343.344	250,141
2025-05-05	IPSCCentury Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−1,024 sh	$0.55	−$563.2	250,693
2025-03-11	IPSCCentury Therapeutics, Inc.A Award	Chief Operations Officer	AAward	+120K sh	—	—	251,717
2025-03-11	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Operations Officer	AAward	+120K sh	—	—	120,000
2025-03-10	IPSCCentury Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−2,359 sh	$0.61	−$1,450.785	131,717
2025-02-03	IPSCCentury Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−1,054 sh	$0.78	−$822.12	134,076
2024-11-04	IPSCCentury Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−1,033 sh	$1.23	−$1,267.491	135,130
2024-08-05	IPSCCentury Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−1,073 sh	$1.83	−$1,960.371	136,163
2024-05-03	IPSCCentury Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−913 sh	$3.11	−$2,835.778	137,236
2024-03-07	IPSCCentury Therapeutics, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+22.8K sh	$1.03	+$23.5K	136,980
2024-03-07	IPSCCentury Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−22.8K sh	$5.14	−$117K	114,149
2024-03-07	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−22.8K sh	—	—	168,655
2024-03-07	IPSCCentury Therapeutics, Inc.A Award	Chief Operations Officer	AAward	+24K sh	—	—	138,149
2024-03-07	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Operations Officer	AAward	+146K sh	—	—	146,000
2024-03-06	IPSCCentury Therapeutics, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+30.7K sh	$1.03	+$31.6K	144,833
2024-03-06	IPSCCentury Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−30.7K sh	$4.96	−$152K	114,149
2024-03-06	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−30.7K sh	—	—	191,486
2024-02-16	IPSCCentury Therapeutics, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+485 sh	$1.03	+$499.55	114,634
2024-02-16	IPSCCentury Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−485 sh	$4.86	−$2,358.264	114,149
2024-02-16	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−485 sh	—	—	222,170
2024-02-06	IPSCCentury Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−1,784 sh	$4.49	−$8,004.808	114,149
2024-02-05	IPSCCentury Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−2,035 sh	$3.84	−$7,816.435	115,933
2023-02-02	IPSCCentury Therapeutics, Inc.A Award	Chief Operations Officer	AAward	+21.9K sh	—	—	96,093
2023-02-02	IPSCCentury Therapeutics, Inc.A Award	Chief Operations Officer	AAward	+21.9K sh	—	—	117,968
2023-02-02	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Operations Officer	AAward	+131K sh	—	—	131,250
2023-02-02	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Operations Officer	AAward	+131K sh	—	—	131,250
2022-01-25	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Operations Officer	AAward	+105K sh	—	—	105,000

Recent filings

Accepted (ET)
Jun 114
Farid Adrienne0001062993-25-011428
SEC(opens sec.gov)
May 74
Farid Adrienne0001062993-25-008775
SEC(opens sec.gov)
Mar 124
Farid Adrienne0001062993-25-005289
SEC(opens sec.gov)
Feb 54
Farid Adrienne0001062993-25-001756
SEC(opens sec.gov)
Nov 54
Farid Adrienne0001062993-24-018339
SEC(opens sec.gov)
Aug 74
Farid Adrienne0001062993-24-014585
SEC(opens sec.gov)
May 74
Farid Adrienne0001062993-24-009573
SEC(opens sec.gov)
Mar 114
Farid Adrienne0001062993-24-006182
SEC(opens sec.gov)
Mar 84
Farid Adrienne0001062993-24-006058
SEC(opens sec.gov)
Feb 214
Farid Adrienne0001062993-24-003878
SEC(opens sec.gov)

Companies

Century Therapeutics, Inc.Chief Operations OfficerIPSC

Address

C/O CENTURY THERAPEUTICS, INC. 25 N 38TH STREET, 11TH FLOOR

PHILADELPHIA, PA, 19104